P Zhang, H Guan, S Yuan, H Cheng, J Zheng… - Nature …, 2022 - nature.com
MAPK signaling inhibitor (MAPKi) therapies show limited efficacy for advanced thyroid
cancers despite constitutive activation of the signaling correlates with disease recurrence …